Skip to main content

Table 1 Patient demographics and critical illness data

From: Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness

Parameter (n = 41)
Age (years), median [IQR] 61 [55–68]
Male, n (%) 23 (56)
BMI (kg/m2), mean (SD) 29.6 (6.3)
Charlson comorbidity index, mean (SD) 5.5 (3.12)
Admitted to medical ICU, n (%) 30 (73)
Admitted to cardiothoracic ICU, n (%) 11 (27)
SOFA at ICU admission, mean (SD) 8.1 (4.8)
ICU LOS days, median [IQR] 8 [4]
Hospital LOS days, median [IQR] 11.2 [8–19]
MV, n (%) 30 (73)
MV, days, median [IQR]a 3.4 [1–7.7]
CRRT, n (%) 5 (12)
CRRT, days, median [IQR]b 9.8 [6.9–10.1]
ECMO, n (%) 2 (5)
Sedation, n (%) 24 (59)
Sedation, days, median [IQR]c 2 [1–3.25]
Inotropes and pressor, n (%) 25 (61)
Inotropes and pressor, days, median [IQR]d 4 [2–7]
Neuromuscular blocker, n (%)e 2 (5)
Time to first ultrasound measures, days, median [IQR] 1.1 (0.7–1.4)
Time to initial physical therapy session, days, mean (SD) 2.6 (1.84)
Time to initial occupational therapy session, days, mean (SD) 3.2 (2.71)
Number of rehabilitation visits for entire hospital stay, median, [IQR] 6 [4—9.25]
In-hospital mortality, n (%) 5 (12)
  1. IQR = interquartile range; ICU = intensive care unit; BMI = body mass index; SOFA = sequential organ failure assessment; LOS = length of stay; ICU = intensive care unit; MV = mechanical ventilation; CRRT = continuous renal replacement therapy; ECMO = extra-corporeal membrane oxygenation;
  2. aMV duration reported in days as median [IQR] for patients (n = 30) that required MV
  3. bCRRT duration reported in days as median [IQR] for patients (n = 5) that required CRRT
  4. cDuration of sedation reported for patients that received at least one sedative defined as number of days receiving at least one dosage
  5. dDuration of inotrope and pressor for defined as the number of days a patient received at least one dosage
  6. e2 patients received long-term NMB (8 and 23 days, respectively, in addition 23 patients received a one-time 50 mg doses of rocuronium for intubation or surgical procedure) (n = 23, 56%)
\